Eugene P. McFadden

Showing 1-11 of 11 articles

Author Mariano Valdés Chávarri

Coronary interventions

Randomised evaluation of a novel biodegradable polymer-based sirolimus-eluting stent in ST-segment elevation myocardial infarction: the MASTER study

Valdés Chávarri M, Kedev S, Neskovic A, de la Tassa CM, Zivkovic M, Nouche RT, Vázquez-González N, Bartorelli A, Antoniucci D, Tamburino C, Colombo A, Abizaid A, McFadden E, Garcia-Garcia H, Milasinovic D, Stankovic G

April 5, 2019 | 10.4244/EIJ-D-17-01087

Author Chourmouzios A. Arampatzis

Coronary interventions

Graft failure prior to discharge after coronary artery bypass surgery: a prospective single-centre study using dual 64-slice computed tomography

Arampatzis C, Chourmouzi D, Boulogianni G, Lemos P, Pentousis D, Potsi S, Moumtzouoglou A, Papadopoulou E, Grammenos A, Voucharas C, Mpismpos A, McFadden E, Drevelengas A

October 10, 2016 | 10.4244/EIJV12I8A160

Author Gastón A. Rodríguez-Granillo

Quantification of scientific output in cardiovascular medicine: a perspective based on global data

Rodríguez-Granillo G, Rodríguez A, Bruining N, Milei J, Aoki J, Tsuchida K, del Valle-Fernández R, Arampatzis C, Ong ATL, Lemos P, Ayala F, Garcia-Garcia H, Saia F, Valgimigli M, Regar E, McFadden E, Biondi-Zoccai G, Barbenza E, Schoenhagen P, Serruys P

December 27, 2013 | 10.4244/EIJV9I8A163

Author Pascal Vranckx

Clinical event committees in coronary stent trials: insights and recommendations based on experience in an unselected study population

Vranckx P, McFadden E, Mehran R, Cutlip D

July 27, 2012 | 10.4244/EIJV8I3A56

Author Elvin Kedhi

Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial

Kedhi E, Gomes M, Joesoef K, Wassing J, Goedhart D, McFadden E, Smits P, investigators t

April 20, 2012 | 10.4244/EIJV7I12A217

Author Marco Valgimigli

Use of Impella Recover® LP 2.5 left ventricular assist device during high-risk percutaneous coronary interventions; clinical, haemodynamic and biochemical findings

Valgimigli M, Steendijk P, Serruys P, Vranckx P, Boomsma F, Onderwater E, Vaina S, Ligthart J, McFadden E, van der Ent M, de Jaegere P, Sianos G

May 20, 2006

Author G Rodríguez-Granillo

First-in-man prospective evaluation of temporal changes in coronary plaque composition by in vivo intravascular ultrasound radiofrequency data analysis: an Integrated Biomarker and Imaging Study (IBIS) substudy

Rodríguez-Granillo G, Serruys P, McFadden E, van Mieghem CAG, Goedhart D, Bruining N, van der Steen A, van der Giessen WJ, de Jaegere P, Vince D, Sianos G, Kaplow J, Zalewski A, de Feyter P

November 20, 2005

Author M Michels

Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgery

Michels M, Caliskan K, Ong ATL, McFadden E, Kappetein AP, van Domburg R, Serruys P

August 20, 2005

Author Angela Hoye

Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stent

Hoye A, Ong ATL, Aoki J, van Mieghem CAG, Rodríguez-Granillo G, Valgimigli M, Sianos G, McFadden E, van der Giessen WJ, de Feyter P, van Domburg R, Serruys P

August 20, 2005

Author Willem van der Giessen

Assessment of stent dimensions with a novel intracoronary balloon-based system: comparative study versus intravascular ultrasound and quantitative coronary angiography. The CAMUS - Coronary Angioplasty Metricath vs. UltraSound Trial

van der Giessen WJ, Regar E, McFadden E, McDougall I, Serruys P

August 20, 2005

Author Angela Hoye

Treatment of de novo bifurcation lesions: comparison of Sirolimus- and Paclitaxel-eluting stents

Hoye A, van Mieghem CAG, Ong ATL, Aoki J, Rodríguez-Granillo G, Valgimigli M, Tsuchida K, Sianos G, McFadden E, van der Giessen WJ

May 20, 2005

1

Latest news

TAVR in sarcopaenia; CCTA or TEE in LAAC; Iintravascular lithotripsy, read the new issue

(CT scans of a sarcopaenic patient)

October 18, 2019

Medical device regulation in Europe – what is changing and how can I become more involved?

October 18, 2019

New this week: Insights from an International CTO Registry

October 22, 2019

Guidelines, consensus & position papers

When is it best to stop aspirin and who could ultimately benefit?

Aspirin-free antiplatelet regimens after PCI

October 9, 2019

The EuroIntervention health check 2019

October 4, 2019

Last week's JAA: Hydrodynamic function with the ALLEGRA heart valve

October 15, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke